Navigation Links
More heart problems with 2 chemo drugs for breast cancer

SEATTLEWomen who have breast cancer and are treated with two chemotherapy drugs may experience more cardiac problems like heart failure than shown in previous studies, according to a new Cancer Research Network study by Group Health researchers and others in the Journal of the National Cancer Institute.

The study is significant because more and more women are surviving longer with breast cancer, so it's becoming a chronic disease, said lead author Erin Aiello Bowles, MPH, an epidemiologist at Group Health Research Institute. Breast cancer is one of the most common cancers in the United States, with an estimated 232,620 new diagnoses in 2011. Often the cure is problematic, as when chemotherapy causes other health problemsas shown in this study.

Ms. Bowles and her colleagues estimated real-world use of anthracycline and trastuzumab use and their associations with heart failure and cardiomyopathy. Earlier clinical trials had shown that women treated for breast cancer with the drugs anthracycline or trastuzumab were at increased risk for heart failure, cardiomyopathy, or both. Like most clinical trials, the earlier clinical trials excluded large categories of patients, including elderly women and those with other health problems, such as existing heart disease. Excluding these women could make the studies miss what happens in the general population.

"We tried to take a broader look by estimating the risk of heart failure in a more general population," Ms Bowles said. "We looked at all the women in a population with breast cancer, not selected ones. Our study shows that people who are not generally eligible for clinical trialsolder women and those with existing heart failuredo receive these drugs in real life."

In the population-based, retrospective cohort study of 12,500 women diagnosed with invasive breast cancer, the overall risk of developing either heart failure or cardiomyopathy was significantly higher in women on anthracycline alone compared with no chemotherapy, yet similar to results of previous clinical trials. But the overall risk of these cardiac problems was even greater among women who used trastuzumab alone. And the risk among women who used both anthracycline and trastuzumab was greater than previously reported. Also, women receiving anthracyclinewith or without trastuzumabtended to be younger and without other illnesses; by contrast, women on trastuzumab alone tended to be older and have more illnesses.

Chemotherapy can cause cardiac problems through several mechanisms, Ms. Bowles added. "These drugs are toxic," she said. "They kill cancer cells, and sometimes kill other cells in the body, too. These drugs are still important for women with breast cancer to use because we know they improve survival. But as with any drug, people need to be aware of the risks, too."

Contact: Rebecca Hughes
Group Health Research Institute

Related medicine news :

1. Heart Attacks, Strokes Jumped After Japan Earthquake, Study Finds
2. Belly Fat May Hit Your Heart the Hardest
3. Early Stenting Best for Some Heart Patients: Study
4. 2 Common Blood Pressure Meds Fare Equally in Preventing Heart Woes
5. Electronic Cigarettes Have Slight Impact on Heart: Study
6. Energy drinks improve heart function
7. Renal denervation gives better outcomes than drugs in advanced heart failure
8. New Blood Thinner Effient No Better Than Plavix at Preventing Heart Trouble: Study
9. Study examines factors associated with improvement in survival from heart attack in France
10. Spouses of Heart Attack Victims May Face Heightened Depression Risk
11. 2 Tests May Improve Heart Patients Care, Studies Suggest
Post Your Comments:
Related Image:
More heart problems with 2 chemo drugs for breast cancer
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based ... and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored ... 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, single-family ... some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average ... extremely low property-tax rates, which contributes to the relatively lower cost of living ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... at the University of California Berkeley, and other leading institutions in announcing the ... power of institutions to change the way animals are raised for food. , ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, ... more than $100 billion in purchasing power, today announced ... and information. The Newsroom is the online ... industry trends, infographics, expert bios, news releases, slideshows and ... access to a wealth of resources at their fingertips, ...
Breaking Medicine Technology: